Nexium tops pharma websites

How do you know if they really love your drug? As with most everything in human psychology, it's a tea-leaves game--and one teacup ready for your reading pleasure is a new report on the most popular websites among prescription drugs. According to the ranking from comScore, AstraZeneca's Nexium got the most web traffic with more than a million unique visitors.

Next in line was Actos, with a huge increase in hits--a whopping 2399 percent's worth. The Takeda diabetes med drew heightened interest as safety concerns arose about a competitor--and sister drug--Avandia, made by GlaxoSmithKline. Another big gainer was Januvia, Merck's diabetes treatment, which saw its web traffic leap by 329 percent. Januvia didn't crack the top five, however; numbers three, four and five, respectively, were Ambien CR, Gardasil and Lexapro.

- check out the release from comScore
- see the Health Blog post

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.